Statement in the Congressional Record
By Senators Jim Risch and Jeanne Shaheen
Chairman and Ranking Member
U.S. Senate Committe on Small Business & Entrepreneurship
Mr. RISCH. Mr. President, on behalf of myself and my colleague Senator Shaheen, I would like to recognize the contributions made to our nation and its small businesses by the good work of America’s Small Business Development Centers (SBDCs). As Chairman and Ranking Member of the Senate Committee on Small Business and Entrepreneurship, Ranking Member Shaheen and I understand the impact that boosting small businesses makes, with 99.7 percent of all firms across America being small businesses and their employees making up 48 percent of the total workforce.
America’s SBDCs provide small businesses across the country with high-quality, low- or no-cost consulting, and a variety of educational programs. These centers operate in all 50 States to support an established network of small businesses while encouraging new entrepreneurs to develop and execute their unique vision, helping innovators get their own small businesses up and running. (more…)



“The SBDC was a huge part of this success. They kept us dreaming,” said Gros. She re-imagined her vision to include several re-purposed containers that would convene the community through craft food and drinks. The SBDC then helped Kim with her financial projections, her lease agreements for her eight vendors, and assisted her in obtaining a loan for the project.
No company has cracked the code for choosing the best chemotherapy for an individual patient, despite the broad range of molecular breast cancer tests available today. Trial-and-error is still the mainstream available path. Currently, the majority of patients start their treatment journey with the ‘standard-of-care’, taxane-based regimen. Due to the low response rates to this regimen (25%), when patients are offered the next level of treatment they have already been exposed to side effects for about six months, which is painful for patients (e.g., immune system debilitation, nausea, hair loss and exposure to unnecessary toxicity). Imagine if we knew who was a good candidate for the ‘standard-of-care’ and who should go straight to ‘Plan B’ while their immune systems are still strong.